Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 6, Issue 5, Pages e1751-e1751
Publisher
Springer Nature
Online
2015-05-07
DOI
10.1038/cddis.2015.120
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The therapeutic value of targeting inflammation in gastrointestinal cancers
- (2014) Beicheng Sun et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Overexpression of gankyrin in mouse hepatocytes induces hemangioma by suppressing factor inhibiting hypoxia-inducible factor-1 (FIH-1) and activating hypoxia-inducible factor-1
- (2013) Yu Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Multiple interactive factors in hepatocarcinogenesis
- (2013) Jin Ding et al. CANCER LETTERS
- p53 promotes inflammation-associated hepatocarcinogenesis by inducing HMGB1 release
- (2013) He-Xin Yan et al. JOURNAL OF HEPATOLOGY
- Recent advances in understanding inflammation and remodeling in the airways in chronic obstructive pulmonary disease
- (2013) Sukhwinder Singh Sohal et al. Expert Review of Respiratory Medicine
- From Cirrhosis to Hepatocellular Carcinoma: New Molecular Insights on Inflammation and Cellular Senescence
- (2013) Gayatri Ramakrishna et al. Liver Cancer
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
- (2012) Dianne H. Dapito et al. CANCER CELL
- p28GANK Prevents Degradation of Oct4 and Promotes Expansion of Tumor-Initiating Cells in Hepatocarcinogenesis
- (2012) You–Wen Qian et al. GASTROENTEROLOGY
- Gankyrin promotes breast cancer cell metastasis by regulating Rac1 activity
- (2012) C Zhen et al. ONCOGENE
- Cellular Function of RhoGDI-α Mediates the Cycling of Rac1 and the Regulation of Pancreatic Beta Cell Death
- (2012) Y. Cho et al. TRANSPLANTATION PROCEEDINGS
- The role of JNK in the development of hepatocellular carcinoma
- (2011) Madhumita Das et al. GENES & DEVELOPMENT
- Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells
- (2011) Wen Sun et al. HEPATOLOGY
- p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathways
- (2010) Jing Fu et al. HEPATOLOGY
- Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents
- (2010) Le-Xing Yu et al. HEPATOLOGY
- The protective role of hydrogen-rich saline in experimental liver injury in mice
- (2010) HanYong Sun et al. JOURNAL OF HEPATOLOGY
- Evolving challenges in hepatic fibrosis
- (2010) Scott L. Friedman Nature Reviews Gastroenterology & Hepatology
- Mouse Models of Hepatocellular Carcinoma
- (2010) Nelson Fausto et al. SEMINARS IN LIVER DISEASE
- Modulation of Hepatic Fibrosis by c-Jun-N-Terminal Kinase Inhibition
- (2009) Johannes Kluwe et al. GASTROENTEROLOGY
- TNF-α/cycloheximide-induced apoptosis in intestinal epithelial cells requires Rac1-regulated reactive oxygen species
- (2008) Shi Jin et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Rac Activation and Inactivation Control Plasticity of Tumor Cell Movement
- (2008) Victoria Sanz-Moreno et al. CELL
- Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation
- (2008) Lijian Hui et al. JOURNAL OF CLINICAL INVESTIGATION
- Experimental models of hepatocellular carcinoma
- (2008) Philippa Newell et al. JOURNAL OF HEPATOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started